Global Bio Banking Market

The Global Bio-banking Market size was valued at USD 34.20 Billion in 2023 and the total Global Bio-banking Market revenue is expected to grow at a CAGR of 8.63 % from 2024 to 2030, reaching nearly USD 61.05 Billion.

Bio-banking Market Overview

Biobanking is defined as the process of collection, processing, storage, and management of biological material such as human/animal plant tissues, blood, cells, and DNA at optimal conditions for scientific/clinical uses. These biobanks are central components to genetic epidemiological and population-based research and capabilities to examine gene-environment and gene-life style effect studies. A significant one is used in Biomedical research for diseases such as heart disease, cancer, asthma, and Mental illness among others, and in developing new treatments and biomarkers in the Global Bio-banking Market. During biobanking, issues like ethics, consent, and confidentiality are critical in implementing biobanking because they address participants’ privacy.

Most biobanks, affiliated with large-scale governmental population-based research projects, target high subject numbers; thus, the intended biobank ‘All of Us’ plans to recruit one million individuals. Extension of biobanks donated by industries such as the Shanghai Zhangjiang Biobank also plays a major part. The International Society for Biological and Environmental Repositories or ISBER aids the management and new perspectives focusing on the problems arising in the Global Bio-banking Market by providing universalism on pertinent standards. When it comes to geographical segregation the market is dominated by the North American region. Some of the forces such as Improvement in Biomedical Studies and Precision Medicine Schemes are considered to shape the market. Opportunities for the market to grow that is associated with the advancement of Personalised medicine.

To know about the Research Methodology:-Request Free Sample Report

Global Bio-banking Market Dynamics

Advancements in Biomedical Research

Biobanks as main facilities offer biological samples, including blood, tissues, DNA, and related data for use in research activities. This is because with an increase in biomedical research more advanced biological specimen is needed hence the biobank across the globe giving rise to the Global Bio-banking Market. The advent of the Human Genome Project as well as other large-scale genomic studies has therefore led to a high demand for biobanks to store samples such as genetic specimens. For instance, the United Kingdom Biobank and the Framingham Heart Study possess massive repositories of data connecting genetic profiles with health-related results and promoting more investigative work on the concept of precision medicine.

Precision Medicine Initiatives

Precision medicine takes into account the differences in genes and environment as well as the lifestyle of the people for making improved decisions in the Global Bio-banking Market. Biobanks have a critical function by offering large volumes of data and material that will help researchers pinpoint biomarkers and begin exact cure manifestations. The All of Us Research Program in the United States plans to obtain the health details of one million individuals to advance the area of precision medicine. Some examples of Institutional Biobanks include the Mayo Clinic Biobank for the study of the correlation of genomic information with health data, containing biological samples for the development of targeted therapies.

Market Growth Opportunities

Growth of Personalised medicine

Biobanks are utilized in patient-centric medicine through the support of large-scale phenotype/genotype datasets and specimens. Possible ways to progress the field are related to increasing the populations within biobanks, focusing on minoritized and rare disease patient groups, as these could provide new biomarkers and individualized treatment approaches. Mayo Clinic’s Biobank has collected more than 50,000 biospecimens associated with detailed clinical registry data. This provides researchers with a large and diverse genetic population that is linked to diseases hence aiding researchers in the global Bio-banking Market to come up with precise genetic treatment plans for patients with such diseases. Possibilities of the extension of biobanks including various populations and rarely diagnosed disease groups It becomes the task of further development to expand biobanks that now encompass different populations for example, multi-ethnic for cardiovascular personalized medicine in Framingham.

Sustainability of funding

Technological advancement and growth of these collections need to be sustained through financial support, which is a basic necessity for biobanks. The main issue with funding tends to attain stable sources of funding which is quite difficult to find, especially for relatively small biobanks and those situated in areas or countries that do not have much funding for research. Again, high levels of grants, government funding, and philanthropic funding mean that there is a need for proper funding models that will support the long-term sustainability of the Global Bio-banking Market. The UK Biobank obtained £200 million in government grants, but other small biobanks often fail to obtain long-term funding thus that calls the question their capacity to retain good quality samples and meet research needs.
Bio-banking Market Segment Analysis

Based on Product & Services

Characterizing the Global Bio-banking Market based on the Product & Service segment, the dominance of the equipment segment is boosted by several factors. The general operation of biobanks depends greatly on the quality of the equipment that is used to preserve and store the biospecimens. This requirement is boosted by another one which refers to the need to strictly control the environmental conditions such as low temperatures for sample preservation. Sample and liquid handling robots are other tools that boost the functionality and productivity of biobanks while at the same time reducing the chances of errors. These specialized instruments are a considerable percentage of the capital that one is likely to spend during the setting up and functioning of the biobank.

The prominent followers of the global biobanking equipment market include Thermo Fisher Scientific, Panasonic Healthcare, Hamilton Company, and others. Their leading articles encompass a great number of biobanks and research centers, correspondingly offering numerous applications related to genomics, pharmaceuticals, and individualized medicine. In addition to helping with the collection, storage, processing, and analysis of biological samples, these technologies help to develop and progress biological science and clinical application. The leadership position of the equipment segment, once again, highlights its importance to biobanks to meet various quality and operational requirements widely necessary for advanced biomedical research and therapeutic advancement in the Global Bio-banking Market.

Based on End Use Industry:

In the Global Bio-banking Market, it is usually observed that major market Players are pharmaceutical & Biotechnology Companies and CROs. This segment, in turn, is considered the largest user of biobanking services since it requires large amounts of biological samples and related data in the development of new drugs and the performance of trials. Pharmaceutical companies, Biologic al technologies firms, and CROs need well-annotated samples for the confirmation of target, and disease pathways and to check the efficiency as well as toxicity profile of the prospective drug. Biobanks play a great role in the provision of biomarkers as well as in creating strategies for personalizing medical treatment. Currently, multinational pharmaceutical firms such as Pfizer, Novartis, and Roche, Contract Research Organizations or CROs including Covance, a part of Labcorp Drug Development, and ICON plc use specialized services of biobanking.

Global Bio-banking Market Regional Insights

North America has long occupied a dominant position in the global Bio-banking Market due to several factors. There is high development in the health sector with popular hospitals, research centers, and biotechnology companies in the region most of their research and development activities rely on biobanking services. Huge expenditures on biomedical studies by incorporating government support from the likes of the NIH in the United States explain the increased need for biobanking commodities. Many pharmaceutical and biotechnology companies in North America depend on biobanks to obtain properly annotated biospecimens whether for drug development, testing on recovered patients, and for implementing associated individualized medicine programs.

In the North American region specifically, biobanks experience fewer legal issues due to the establishment of clear and highly appropriate rules and conduct by the Food and Drug Administration. These regulations aim at controlling the usage of the biobank samples in the right manner and protecting the privacy of data increasing the chances of people in the Global Bio-banking Market more reliable and to adhere to the set regulations. NHBI and Mayo Clinic Biobank are some of the well-developed biobanks and research networks to add to North America’s dominance in the global marketplace.

For example, the NIH Biobank is among the world’s largest biobanks aimed at providing users with large collections of biological samples associated with health data in the Global Bio-banking Market. It funds various research projects including genomic, epidemiology, and personalized medicine. Along the same line of reasoning, mighty expenditures in biomedical research have been made by the Mayo Clinic Biobank situated in Minnesota which underlines the case of biobanking innovation. This biobank helps Mayo Clinic in its research activities such as probing for disease causation, tailoring treatments for patients as well as enhancement of trial processes. In general, North America has a well-developed environment of healthcare innovation, strict regulation, and well-developed biobanking systems, which puts this region on top of the biobanking development around the world and in this way contributes to biomedical research and individualized treatment.

Scope of Global Bio-banking Market: Inquire before buying

Global Bio-Banking Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Global Bio-banking Market, Key Players

1. Thermo Fisher Scientific, Inc. (US)
2. PHC Holdings Corporation (Japan)
3. QIAGEN N.V. (Germany)
4. Merck KGaA (Germany)
5. Avantor, Inc. (US)
6. Cryoport, Inc. (US)
7. Tecan Trading AG (Switzerland)
8. Azenta, Inc. (US)
9. Greiner Holding AG (Austria)
10. Hamilton Company (US)
11. AMSBIO (UK)
12. Bay Biosciences LLC (US)
13. BioKryo (Germany)
14. SPT Labtech (UK)
15. ASKION GmbH (Germany)
16. Cell&Co BioServices (France)
17. Ziath Ltd. (UK)
18. CTIBiotech (France)
19. Careline (US)
20. Firalis S.A. (France)
21. Sopachem (Netherlands)
22. ProteoGenex (US)
23. US Biolab Corporation, Inc. (US)
24. Shanghai Zhangjiang Biobank
25. EuroBioBank network

Frequently Asked Questions:
1] Which segment dominates the Global Bio-banking Market?
Ans. The Product and service segment dominates the Global Bio-banking Market.

2] Which region held the largest Global Bio-banking Market share in 2023?
Ans. The North American region held the largest Global Bio-banking Market share in 2023 in which the U.S. was the leading country.

3] What is the expected Global Bio-banking Market size by 2030?
Ans. The Global Bio-banking Market size is expected to reach US$ 61.05 Bn by 2030.

4] What was the key driver of the Global Bio-banking Market?
Ans. Advancements in Biomedical Research and Precision Medicine Initiatives are key drivers in the Global Bio-banking Market.

5] What is the expected CAGR of the Global Bio-banking Market during the forecast period?
Ans. The expected CAGR of the Global Bio-banking Market is 8.63% during the forecast period.